Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Predemtec logo — Setting new standards in Alzheimer's Diagnostics

Predemtec

Setting new standards in Alzheimer's Diagnostics

Founded 2017 Germany Berlin, Germany 1 employees Seed Biotechnology, Developer Tools +1

General Information

Company Name Predemtec
Founded Year 2017
Location Germany Berlin, Germany
Employees 1
Industries Biotechnology, Developer Tools, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Predemtec. To contact Predemtec, visit predemtecdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Predemtec compare?

A PDF of Predemtec and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Predemtec soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Predemtec

Predemtec is a biotechnology company based in Germany that is setting new standards in Alzheimer's Diagnostics. The company was founded in 2011 and has developed a blood test for the accurate diagnosis of Alzheimer's disease.

The company's innovative approach to diagnosing Alzheimer's disease has garnered attention from investors, with their last investment being a Seed Round investment on 31 July 2014. This round of investment was led by HTGF | High-Tech Gruenderfonds, a prominent venture capital firm.

With its focus on cutting-edge technology and healthcare, Predemtec presents an intriguing opportunity for investors looking to support advancements in the biotechnology and healthcare industries.

Business keywords: Alzheimer's disease, Diagnostics, Blood test, Predemtec, DX test, Senile dementia, Immunoassay, Diagnostic tests, Risk factors, Biomarkers, Serum-based test, Annegret Feuerhelm-Heidl, Healthcare innovation, Medical technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
HTGF | High-Tech Gruenderfonds
31 Jul 2014

Predemtec Alternatives & Competitors

View All Alternatives
Predemtec vs
Maven Biotechnologies
Maven Biotechnologies

Transforming respiratory, infectious, and autoimmune disease with Point of Care diagnostics.

Grant
1 employees
Big Data, Biotechnology
Predemtec vs
AgenT
AgenT France

Detect Alzheimer's earlier, when it could be prevented

39 employees
Biotechnology, Health Care
Predemtec vs
AMONETA DIAGNOSTICS
AMONETA DIAGNOSTICS France

Early diagnosis of Alzheimer's Disease (AD) with a single drop of blood.

Equity Crowdfunding
5 employees
Biotechnology, Health Care
View all alternatives

FAQ About Predemtec

Setting new standards in Alzheimer's Diagnostics
Predemtec was founded in 2017.
Predemtec is headquartered in Berlin, Germany.
Predemtec operates in Biotechnology, Developer Tools and Health Care. Its work centres on Alzheimer's disease, Diagnostics, Blood test and Predemtec.
Predemtec has approximately 1 employees.
Predemtec has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Predemtec include Maven Biotechnologies, AgenT, AMONETA DIAGNOSTICS, ADmit Therapeutics, BG Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Predemtec and Maven Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Predemtec, https://bouncewatch.com/company/predemtec, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout